Mental Health Clinics in Evesham, NJ Accepting Medicare
3 Mental Health Clinics found. Showing 1 - 3
 Oaks Integrated Care Clinic - Adult Mental Health Medicare: Not Enrolled in Medicare Practice Location: 538 Kettle Run Rd, Evesham, NJ 08053 Phone: 609-267-5928 |
Oaks Integrated Care Clinic - Adolescent and Children Mental Health Medicare: Not Enrolled in Medicare Practice Location: 239 Chestnut Ave, Evesham, NJ 08053 Phone: 609-267-5928 |
Twin Oaks Community Services, Inc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 239 Chestnut Ave, Evesham, NJ 08053 Phone: 609-267-5928 |
News Archive
AdvanSource Biomaterials submits plan to NYSE Amex for compliance with listing standards
AdvanSource Biomaterials Corporation, a leading developer, manufacturer and seller of advanced polymer technologies and materials for a broad range of medical devices, today announced it has submitted a plan advising the NYSE Amex of the actions it has taken and will take to bring the Company into compliance with certain listing standards of the NYSE Amex by February 17, 2012.
Researchers say access to primary care doesn't always guarantee better health
Kaiser Health News staff writer Jordan Rau reports on a new findings by Dartmouth researchers. "A study released Thursday challenges two widely-held assumptions about medical care: that people who see a primary care physician will end up healthier than those who don't, and that having more primary care doctors in an area guarantees better access for patients"
New genetic test can predict cleft lip or palate
Researchers have developed a new genetic test that can help predict whether parents who have one child with the "isolated" form of cleft lip or palate are likely to have a second child with the same birth defect. Isolated clefts account for 70 percent of all cleft lip and palate cases.
Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011
Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in gastrointestinal stromal tumors (GIST) and a Phase 1 trial of ganetespib in solid tumors evaluating a twice-weekly administration schedule.
› Verified 6 days ago